Follow
Krishna Chimalakonda, Ph.D.
Krishna Chimalakonda, Ph.D.
Scientist, Office of Generic Drugs, U.S. Food and Drug Administration
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands
KC Chimalakonda, KA Seely, SM Bratton, LK Brents, CL Moran, ...
Drug metabolism and disposition 40 (11), 2174-2184, 2012
2202012
Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine
CL Moran, VH Le, KC Chimalakonda, AL Smedley, FD Lackey, SN Owen, ...
Analytical chemistry 83 (11), 4228-4236, 2011
2032011
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure
AL Patton, KC Chimalakonda, CL Moran, KR McCain, ...
Journal of forensic sciences 58 (6), 1676-1680, 2013
1252013
Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine
KC Chimalakonda, CL Moran, PD Kennedy, GW Endres, A Uzieblo, ...
Analytical chemistry 83 (16), 6381-6388, 2011
1162011
Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases
KC Chimalakonda, SM Bratton, VH Le, KH Yiew, A Dineva, CL Moran, ...
Drug metabolism and disposition 39 (10), 1967-1976, 2011
1132011
Synthesis, analysis, in vitro characterization, and in vivo disposition of a lamivudine–dextran conjugate for selective antiviral delivery to the liver
KC Chimalakonda, HK Agarwal, A Kumar, K Parang, R Mehvar
Bioconjugate chemistry 18 (6), 2097-2108, 2007
482007
Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology
AL Patton, KA Seely, KC Chimalakonda, JP Tran, M Trass, A Miranda, ...
Analytical chemistry 85 (19), 9390-9399, 2013
422013
Nonclinical evaluation of the potential for mast cell activation by an erythropoietin analog
HKE Weaver JL, Boyne M, Pang E, Chimalakonda K
Toxicol Appl Pharmacol. 287 (3), 246-52, 2015
302015
Development and validation of a liquid-chromatography tandem mass spectrometry method to determine in vitro and in vivo histamine release
KCC Eric Pang, James L. Weaver, Kristina E. Howard, Vikram Patel, Michael T ...
Journal of Pharmaceutical and Biomedical Analysis 102, 494-499, 2015
22*2015
Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/spice
K C Chimalakonda, L P James, A Radominska-Pandya, J H Moran
Drug metabolism letters 7 (1), 34-38, 2013
162013
Development and validation of an LC-MS/MS method for determination of phencyclidine in human serum and its application to human drug abuse cases
KC Chimalakonda, C Hailey, R Black, A Beekman, R Carlisle, ...
Analytical methods 2 (9), 1249-1254, 2010
92010
Concise Synthesis of Potential 4-Hydroxy-5-fluoropentyl Side-Chain Metabolites of Four Synthetic Cannabinoids
J Wallgren, A Rexander, E Vestling, H Liu, J Dahlén, P Konradsson, X Wu
Synlett 31 (05), 517-520, 2020
32020
Selective Targeting of Anti-viral Drug Lamivudine to the Liver
KC Chimalakonda
Texas Tech University Health Sciences Center, 2008
12008
DMD# 47530
KC Chimalakonda, KA Seely, SM Bratton, LK Brents, CL Moran, ...
2012
Human Metabolism of Synthetic Cannabinoids
KC Chimalakonda
University of Arkansas for Medical Sciences, 2012
2012
Selective targeting of the anti-viral agent lamivudine to the liver
KC Chimalakonda
2007
The system can't perform the operation now. Try again later.
Articles 1–16